{
  "id": "62121a463a8413c653000015",
  "type": "list",
  "question": "What are the currently FDA approved monoclonal antibodies for myeloma?",
  "ideal_answer": "The US Food and Drug Administration approved MoAbs, include belantamab mafodotin, daratumumab, elotuzumab, and isatuximab.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/34549911"
  ],
  "snippets": [
    {
      "text": "In this review, we highlight the current US Food and Drug Administration approved MoAbs, namely, belantamab mafodotin, daratumumab, elotuzumab, and isatuximab. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34549911",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "belantamab mafodotin, daratumumab, elotuzumab, isatuximab"
}